Patent Assignment
Reel/Frame 050520/0149
Release of Security Interest
Recorded: 2019-09-27
Pages: 5
Assignor
WILMINGTON SAVINGS FUND SOCIETY, FSB
Executed: 2019-09-26
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Properties
(10)
Compositions and Methods for Reducing Major Adverse Cardiovascular Events
Compositions for Affecting Weight Loss
Compositions and Methods for Weight Loss in at Risk Patient Populations
Methods For Administering Weight Loss Medications
Sustained Release Formulation Of Naltrexone
Application:
16/284,453 →
Publication:
US 2019/0183883
Method for Treating Obesity
Application:
16/293,198 →
Publication:
US 2019/0262318
Compositions And Methods For Weight Loss In At Risk Patient Populations
Compositions And Methods For Reducing Major Adverse Cardiovascular Events
Compositions For Affecting Weight Loss
Compositions And Methods For Increasing Insulin Sensitivity
Application:
16/378,177 →
Publication:
US 2019/0231852
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 24, 2017
From: WEBER, ECKARD; COWLEY, MICHAEL ALEXANDER
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041730/0170 →
Assignment of Assignor's Interest
Mar 28, 2017
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041765/0767 →
Assignment of Assignor's Interest
Jan 9, 2018
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 044578/0150 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest
Sep 20, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 047115/0102 →
Security Interest
May 6, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 049092/0156 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →